fda approval for semaglutide US approves weight loss drug Wegovy to prevent cardiovascular events Semaglutide shortage ends as FDA

Semaglutide is a revolutionary GLP-1 receptor agonist that was originally developed for patients with Type 2 diabetes, but when providers and pharmaceutical developers noticed how much weight their patients were losing, they began to study semaglutide exclusively for weight loss

Your doctors can assess your risk based on your medical and family history, lab results, and dietary habits (6)

Understanding when side effects hit after taking semaglutide helps you plan your meals strategically

Hormones such as growth hormone play a role in metabolism, muscle maintenance, and fat utilization

Our team works closely with patients to integrate semaglutide into a comprehensive weight management plan that includes lifestyle modifications to enhance results